ロード中...
Engineered Liver Platforms for Different Phases of Drug Development
Drug-induced liver injury (DILI) remains a leading cause of drug withdrawal from human clinical trials or the marketplace. Due to species-specific differences in liver pathways, predicting human-relevant DILI using in vitro human liver models is critical. Microfabrication tools allow precise control...
保存先:
| 出版年: | Trends Biotechnol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5253249/ https://ncbi.nlm.nih.gov/pubmed/27592803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tibtech.2016.08.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|